Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Ile-Asp-Ser)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences peak height
ST001008 AN001650 Multi-Platform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity (part II) Intestine Mouse Pennsylvania State University ppm
ST001299 AN002163 Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran Intestine Mouse The Pennsylvania State University (Penn State) ppm
  logo